ERBB2 and breast cancer: According to a gene expression profile analysis, the PyMT tumor closely resembles the aggressive forms of the luminal B subtype of human BC, exhibiting loss of ER and PR expression and overexpression of HER2 and cyclin D1 with the progression of the disease (108).